The review explains that consuming green tea can help prevent against ovarian, endometrial, cervical, and various other forms of gynecologic cancers, according to Natural News.
 
Green tea is gaining worldwide attention for its myriad of catechins, flavonoids, polyphenols, and other nutritive compounds that each possess their own unique healing capabilities. Green tea polyphenols has proven chemo-protective properties, while green tea catechins has proven antiviral and immuno-modulating properties. These compounds synergistically strengthen the body and protect it against the development and spread of malignant cancer cells.

Now, though, the concern remains. It’s not a constant worry, not something I jump to immediately. I do not live a paranoid existence, waiting for the next health shoe to drop. But occasionally, when I have a minor issue, two and two adds up to cancer in my crazy mind.

I have a history of stomach ulcers, which I usually can control with diet. It has been almost eight years since they bothered me. Lately, though, I have ignored my usual healthy eating and have been having too much Diet Coke, fried foods, and coffee.

So my stomach has been hurting. I self-medicate — antacids, aloe vera juice, lots of water. And, of course, no Diet Coke, fried foods, and coffee. And I am fine.

"The more cruciferous vegetables you eat, the better off you are," says researcher Sarah J. Nechuta, MPH, PhD, a postdoctoral research fellow at Vanderbilt University in Nashville, Tenn.

It's easy to get 150 grams of these veggies in your diet, Nechuta tells WebMD. A cup of cooked broccoli, cauliflower, Brussels sprouts, mustard greens, cabbage, and kale all weigh about 150 grams.

The study isn’t the first to suggest that eating the crunchy vegetables may benefit women with breast cancer. But it's one of the largest.

The findings were presented here at the annual meeting of the American Association for Cancer Research.

This time, however, the vomiting persisted. By the time she arrived at our hospital, she was so dehydrated that the skin on her face looked like fine crepe hanging from her brow and cheekbones.

Some of the doctors who heard her story were certain she needed an operation. That debilitating kink, they thought, could be snipped away in minutes by a surgeon’s skilled hand!

But her own surgeon held off. He explained that finding the precise band of scar causing her obstruction would be difficult and perhaps dangerous. With all the dense scarring from her previous operations and radiation, he wasn’t certain that he could find the offending kink, nor that his patient would necessarily benefit from surgery.

Instead, he gave her intravenous hydration and decompressed her intestines with a small tube threaded though her nose into her stomach. After a week, the woman was eating again and ready to go home.

Read more…

Cadmium, which is found in many farm fertilizers, can make its way into soil and water, the researchers explained. Some of the main sources of cadmium in the diet are bread and other cereals, potatoes, root crops and vegetables. Once it enters the body, cadmium may mimic the effects of the female hormone estrogen, which can fuel the growth of certain breast cancers.

"Modern life has become increasingly dangerous for our breast health," said Dr. Marisa Weiss, director of breast radiation oncology and breast health outreach at Lankenau Medical Center in Wynnewood, Pa. "Now, there's cadmium hanging onto our carrots and whole grains, the very vegetables that are supposed to be good for us," she noted.

"To help our patients reduce their exposure to environmental chemicals (like cadmium), which might increase their risk for breast cancer, we have to partner with our farmers to make sure our foods are grown in healthy soil without chemically loaded fertilizers," said Weiss, who is also president and founder of Breastcancer.org. "Sticking to real, whole (unprocessed) foods remains a healthy strategy until we can be more sure of what's inside the package."

In the Swedish study, the researchers followed close to 56,000 women for more than 12 years. Women filled out food frequency questionnaires, which the researchers used to estimate how much cadmium they consumed in their diets. There were 2,112 breast cancer diagnoses during the follow-up period, including 1,626 estrogen receptor-positive and 290 estrogen receptor-negative cancers.

Dr. Jennifer Ligibel, a medical oncologist at the Dana-Farber Cancer Institute, Boston, USA, and an Associate Professor at Harvard Medical School, and colleagues, studied data from 1909 patients who were enrolled into a study called CALGB 9741 between 1997 and 1999. The study was set up to investigate different dosing schedules for adjuvant chemotherapy in patients where cancer cells were found in the lymph nodes (node-positive cancer). The presence of such cells in the lymph nodes means that there is a higher chance of cancer returning after surgery.

After extracting height and weight data from the patient records, they went on to evaluate the relationship between body mass index (BMI) with relapse-free survival (RFS) and overall survival (OS). 1.2% of the patients were underweight, 32.6% normal weight, 32.9% overweight, and 33.3% obese. 49% of patients were menopausal, 65% had oestrogen-receptor positive cancers, where the presence of oestrogen encourages the tumour to grow, and 70% received the oestrogen-receptor blocking treatment, tamoxifen.

"Several other studies have shown that being overweight or obese at the time that a woman is diagnosed with breast cancer is linked to a higher risk of recurrence. However, questions have been raised in the past whether obese women were receiving relatively lower doses of chemotherapy due to their weight. Our study mandated that each patient received a chemotherapy dose adjusted to her weight, so these results suggest that treatment factors are not responsible for the differences in recurrence rates seen in heavier women," Dr. Ligibel will say. "We found that BMI was related to both RFS and OS; for example, the ten-year RFS of a patient who was overweight was 70%; compared with 65% for one who was obese."

Cadmium, which is found in many farm fertilizers, can make its way into soil and water, the researchers explained. Some of the main sources of cadmium in the diet are bread and other cereals, potatoes, root crops and vegetables. Once it enters the body, cadmium may mimic the effects of the female hormone estrogen, which can fuel the growth of certain breast cancers.

"Modern life has become increasingly dangerous for our breast health," said Dr. Marisa Weiss, director of breast radiation oncology and breast health outreach at Lankenau Medical Center in Wynnewood, Pa. "Now, there's cadmium hanging onto our carrots and whole grains, the very vegetables that are supposed to be good for us," she noted.

"To help our patients reduce their exposure to environmental chemicals (like cadmium), which might increase their risk for breast cancer, we have to partner with our farmers to make sure our foods are grown in healthy soil without chemically loaded fertilizers," said Weiss, who is also president and founder of Breastcancer.org. "Sticking to real, whole (unprocessed) foods remains a healthy strategy until we can be more sure of what's inside the package."

Read more…

Experts found women may be likely to be harmed by the programme and undergo unnecessary surgery, especially in the first decade of being screened.

James Raftery, professor of health technology assessment at the University of Southampton, led the new study which examined data from the 1986 Forrest report.

The Forrest report, which led to the introduction of breast cancer screening in the UK, determined the benefits of screening in terms of quality adjusted life years or QALYs (a measure of quantity and quality of life).

It found about 3,000 QALYs in terms of lives saved over a 20-year period for every 100,000 women who were invited for screening. But at the 10-year mark, the number of QALYs stood at only about 1,000.

In a retrospective study, lower vitamin D levels were significantly associated with larger tumor size (P=0.0063), Barbara Brouwers, PhD, of the University of Leuven in Belgium, reported during a poster session at the San Antonio Breast Cancer Symposium here.

"Lower vitamin D levels were correlated with much bigger tumors," she told MedPage Today. "We also saw that higher vitamin D levels were associated with better outcomes, but it wasn't significant."

Brouwers explained that many studies have shown that vitamin D status is important in many chronic illnesses, and some have even shown low vitamin D levels to be a risk factor for breast cancer, as well as a predictor of outcomes.

Yet it's difficult to interpret its specific role given the many confounding factors known to influence serum concentrations, such as dietary intake, seasonal variation, and weight.

Also, genetic variants regarding vitamin D metabolism could influence risk, she added.

The researchers stressed that a larger, longer-term additional study is required.

Michelle Harvie, Ph.D., SRD, a research dietician at the Genesis Prevention Center, who presented the study said:

"Weight loss and reduced insulin levels are required for breast cancer prevention, but [these levels] are difficult to achieve and maintain with conventional dietary approaches."

Harvie and her team set out to compare three different 4-month-long diets to assess the effects on weight loss and blood markers of breast cancer risk in 115 women who had a family history of breast cancer. The researchers randomly assigned patients into three groups:

By environment they mean everything not governed by genes — what's in the air and water but also diets, vitamin use and even things like working night shifts.

And while they lament that most chemicals in consumer goods get little safety testing, they find too few studies in people to say whether there is a breast cancer risk from certain pesticides, cosmetics or bisphenol A, known as BPA and used in many plastics and canned food liners, although it has been eliminated from baby bottles and many reusable beverage containers in recent years.

"We don't have enough data to say 'toss your water bottles,'" said Irva Hertz-Picciotto, chief of environmental and occupational health at the University of California, Davis.

She headed the Institute of Medicine panel — independent experts under the National Academy of Sciences who advise the government and others. This report was paid for by Susan G. Komen for the Cure, a breast cancer foundation. It was presented Wednesday at a cancer conference in Texas.

The debate about using menopausal hormone therapies to relieve symptoms in post-menopausal women has been ongoing. Is the combination therapy of estrogen and progestin better or worse than just giving women estrogen alone? In women who still have a uterus (those who have not had a hysterectomy), progestin counteracts the increased risk of uterus cancer when estrogen is given alone, but at the expense of an increase in breast cancer risk compared to estrogen alone.

Now a study by researchers at UCLA's Jonsson Comprehensive Cancer Center has found that women taking the combination estrogen and progestin menopausal hormone therapy who experienced new onset breast tenderness had a 33 percent greater subsequent risk of developing breast cancer than women who did not experience breast tenderness. In contrast, among women taking estrogen alone, those who experienced new-onset breast tenderness did not have a higher subsequent risk of breast cancer.

"This study showed that developing new breast tenderness after the start of hormone therapy was associated with increased breast cancer risk only in women on the combination estrogen plus progestin therapy, not estrogen therapy alone." said study first author Dr. Carolyn Crandall, a professor of general internal medicine and a scientist with UCLA's Jonsson Comprehensive Cancer Center

The study appears in the Nov. 17, 2011 in the early online edition of the peer-reviewed journal Breast Cancer Research and Treatment.

A previous study by Crandall, published last month, found that the new onset of breast tenderness was much more pronounced after initiation of estrogen and progestin therapy than in women getting estrogen therapy alone. The association between new onset breast tenderness and changes in breast density also was more pronounced in the women getting the combination hormone therapy.

"The consistent theme we've run across throughout these studies is that estrogen and progestin compared to estrogen alone have a more marked effect on breast tissue," Crandall said. "One theory is that there may be more growth of breast tissue, making the breasts more dense, when women take the combination therapy."

Multiple population studies have shown that higher breast density is associated with a higher risk of breast cancer. In women with extremely dense breasts, the cancer risk can be four to six times higher than for women whose breasts are not dense, Crandall said.

Women taking estrogen did have breast tenderness, though not as much as those on the combination therapy, and it clearly didn't signal an increased risk of breast cancer. Crandall cautioned that women taking hormone therapy in general are only at a slight risk for developing breast cancer overall. A previous study estimated that, out of 10,000 women who take combination estrogen plus progestin hormone therapy for one year, eight additional women developed breast cancer than would have normally have been expected to get the disease.

Dr. Christine Teal had never been flagged for suspicious lumps in her breasts, nor had she tested positive for mutations in the breast cancer susceptibility genes, which greatly increase a woman's risk of developing the disease.

But Teal — who is chief of breast surgery at George Washington University Hospital — nonetheless opted to undergo a preventive double mastectomy, electing to have surgeons remove both her breasts.

"There are genetic breast cancers out there that are not part of BRCA. That was the case with my family," Teal explained. Her mother was twice diagnosed with the disease — most recently with aggressive, stage III cancer — but tested negative for BRCA1 and BRCA2 mutations, meaning Teal herself was never tested.

Yet the breast cancer expert said the sheer aggressiveness of her mother's disease filled her with anxiety.

"For me, it was pretty straightforward," Teal said. "I didn't want to worry for the next 40 years."

For many women, understanding their breast cancer risk and determining what preventive options are available to them are intensely daunting tasks. But new research published last week may lend clarity to at least one piece of the puzzle.

In a study published the Journal Of Clinical Oncology, researchers looked at more than 3,000 families, nearly 300 of which had breast cancer susceptibility gene mutations present.

Women who had first-degree relatives — i.e. mothers, sisters or daughters — with BRCA1 or BRCA2 mutations, but who were themselves negative were at no higher breast cancer risk than average women, the researchers found. That finding runs counter to an earlier study that suggested such "non-carriers" with first-degree relatives still had between a two- and five-fold increased risk of breast cancer.

Women in the study who drank three to six glasses of wine per week were 15 percent more likely than those who did not drink to develop breast cancer, researchers found in reviewing data taken over a 28-year period.

The study adds to the growing body of evidence of a link between alcohol consumption and an increased risk of breast cancer. Drinking moderate to high amounts of alcohol has previously been linked with breast cancer risk, but the effects of consuming low amounts of alcohol had been unclear. Alcohol may be increasing breast cancer risk by altering levels of the sex hormone estrogen, the researchers said.

Still, while the increased risk found in this study is real, it is quite small. Women will need to weigh this slight increase in breast cancer risk with the beneficial effects alcohol is known to have on heart heath, said Dr. Wendy Chen, of Brigham and Women’s Hospital in Boston. Any woman’s decision will likely factor in her risk of either disease, Chen said.

Chen noted that women who consumed fewer than three drinks per week had no increase in breast cancer risk.

“I don’t think the take home message would be that women can’t drink at all,” Chen said.

The research found as few as three to six glasses of wine a week increased the chance of developing breast cancer. The risk of breast cancer rose with the amount of alcohol consumed, the study found, with the best measure of risk being a woman’s cumulative alcohol consumption throughout her lifetime.

“This study doesn’t tell women, ‘Don’t drink at all,’” said Dr. Wendy Chen, lead author and assistant professor of medicine at Harvard Medical School. “It’s really what someone does on average over a long period of time, not what they did this past month, not what they did this past year.”

Previous studies have shown higher alcohol consumption associated with an increased risk of breast cancer. The effects of moderate drinking had not been calculated before.

In this study, funded by the National Institutes of Health, researchers found a 10% increase in risk with each 10 grams (3.5 ounces) per day of alcohol consumed. For example, women who consumed 3-6 glasses of wine per week had a breast cancer risk about 1.15 times higher than women who don’t drink.

There was no difference in cancer risk among wine, beer and liquor when the amount of alcohol in each was considered. Wine has 11 grams of alcohol per 4-ounce serving; beer, 12.8 grams per 12-ounce serving; liquor, 14 grams per standard serving.

More than half of healthy women who have an annual mammogram will get at least one false positive result over a 10-year period, and 7 to 9 percent will undergo a biopsy that doesn't turn out to show cancer, U.S. researchers said Monday.

Having a mammogram every other year instead of every year would cut the risk of a false positive by about a third, but it could result in catching cancers at a later stage, they reported in the Annals of Internal Medicine.

In 2009, the U.S. Preventive Services Task Force, a government-backed advisory panel, issued new guidelines that suggested women should start routine mammograms at age 50 rather than 40, in part because the tests have such high false positive rates and the benefits in lives saved did not outweigh the worry and anguish caused by the false positive results.

The change contradicted years of messages about the need for routine breast cancer screening starting at age 40 and triggered a backlash from cancer doctors and advocacy groups who said the tests save lives and are worth the risk of a false positive test result every now and then.

In the latest study, the researchers analyzed data from a large breast cancer registry that included more than 169,000 women aged 40 to 59 in seven regions around the United States.

Does diet really make a difference when it comes to breast cancer?

Since October is Breast Cancer Awareness month, this is the perfect time to answer this question.

And the answer is a resounding yes. To get you the best possible information, I turned to registered dietitians Sally Scroggs, MS,RD,LD, and Clare McKinley, RD,LD, at the University of Texas M.D. Anderson Cancer Center, one of the leading cancer hospitals in the world. They explained that breast cancer risk could be decreased by up to 38% through lifestyle factors including maintaining a healthy weight, exercising regularly, and eating a healthy diet. In fact, less than 10% of breast cancer appears to have a genetic basis.

For prevention of breast cancer, limiting alcohol to one drink a day (5 ounces of wine, 12 ounces of beer, or 1.5 ounces of spirits) is one of the most important things that you can do. In addition, a plant-based diet loaded with at least two cups a day of a variety of produce is beneficial.

According to the American Institute for Cancer Research, "no single food or food component can protect you against cancer by itself. But scientists believe that the combination of foods in a predominantly plant-based diet may. There is evidence that the minerals, vitamins and phytochemicals in plant foods could interact in ways that boost their individual anti-cancer effects. This concept of interaction, where 1 + 1 = 3, is called synergy."

Some of their top picks for cancer prevention include beans, berries, cruciferous vegetables (broccoli, cauliflower, cabbage, brussels sprouts), dark leafy green vegetables (spinach, kale, chard, romaine, mustard greens), flaxseed, garlic, grapes/grape juice, green tea, soy, tomatoes and whole grains. A recent study in mice suggests that walnuts may also play a role in breast cancer prevention, but these findings need to be confirmed in humans.

Diet wise, keep in mind that the omega-3s found in flax and fish oils have a protective effect against the development of breast cancer.  Japanese women have a very low incidence of breast cancer and they are large consumers of cold water fish rich in the awesome omega-3s.  Get on the right fat track—at least one to two tablespoons of ground flaxseeds (high in hormone-balancing lignans) and/or a minimum of 1 to 2 g of fish oil daily.
 

The women of Mediterranean countries also have a very low incidence of breast cancer and they receive about 40% of total calories from fat—in the form of delicious olive oil, a monounsaturated fat that can be used for salad dressings and stir-frying.
 

There is another promising disease-defying nutrient on the horizon: the antioxidant Coenzyme Q10 (CoQ10). Perhaps best known for its role in preventing heart disease, CoQ10 is so vital to your health that is it found in virtually every single cell in your body. It helps to convert energy in the mitochondria from glucose and oxygen. The highest energy organ of the body—like the heart—needs twice as much CoQ10 as other body parts, but this super supplement has also been linked to the breasts!

During your menstrual cycle, estrogen generally triggers the proliferation of cells in the inner lining of your breasts’ milk glands. Providing you don’t get pregnant, these estrogen levels subsequently drop at the end of your cycle, and those milk gland cells deteriorate and die. Because estrogen can’t really tell the difference between normal cells and cancerous cells, though, it will cause cancerous cells to spread just like it would with regular cells. Many drugs used to treat breast cancer, then, are aimed at selectively blocking the effect of estrogen.

In this recent study, researchers treated breast cancer cells with resveratrol and compared their growth to untreated cells. The growth of those cells treated with resveratrol ended up being significantly reduced; tests showed this cell growth reduction was due to resveratrol drastically reducing estrogen receptor levels.
 

As the buzz of the good news subsided I began to think of my own breast health. I'm still a ways off from the age when the majority of breast cancer cases occur (50+) — and there are factors that up my risk of breast cancer that I can't control, like family history, getting older and (ahem!) being a woman — but there are lifestyle changes I can make now to tip the odds in my favor in the years ahead.
 

At Susan G. Komen, we're busy gearing up for October, which is Breast Cancer Awareness Month, and while I'm buoyed by all the strides we've made in nearly three decades since the breast cancer movement began, I'm still concerned with how far we have yet to go in our fight. So I'm alarmed by numbers that show fewer than 50 percent of American women over 40 with health insurance get a mammogram annually. This is not something we can afford to ignore.
 

When it comes to diet, certain foods are believed to be healthier than others because they contain cancer-fighting compounds in the form of antioxidants. These include many fruits and vegetables, red wine, and green tea. Now, researchers have found that the combination of green tea and mushrooms may have a protective effect.

Phytoestrogens are plant compounds which, in the human body, can attach to the receptors for the female sexual hormone estrogen and which are taken in with our daily diet. A number of findings have attributed a cancer protective effect to these plant hormones. At DKFZ, a team headed by Prof. Dr. Jenny Chang-Claude summarized the results of several studies in a meta-analysis last year and showed that a diet rich in phytoestrogens lowers the risk of developing breast cancer after menopause. Now the Heidelberg researchers wanted to find out whether phytoestrogens also have an influence on the course of breast cancer. Prior investigations on this topic had provided contradictory results.

The most important type of phytoestrogens in our Western diet are lignans, which are contained in seeds, particularly flaxseeds, as well as in wheat and vegetables. In the bowel, these substances are turned into enterolactone, which is absorbed by the mucous tissue and which was determined by the Heidelberg researchers as a biomarker in the patients' blood.

From 2002 to 2005, the DKFZ researchers used the MARIE study to take blood samples of 1,140 women who had been diagnosed with postmenopausal breast cancer. After a mean observation time of six years, they related enterolactone levels to clinical disease progression.

The result: Compared to the study subjects with the lowest enterolactone levels, the women with the highest blood levels of this biomarker had an approximately 40 percent lower mortality risk. When the scientists additionally took account of the incidence of metastasis and secondary tumors, they obtained a similar result: Women with the highest enterolactone levels also had a lower risk for such an unfavorable disease progression.

The findings, published in the American Journal of Epidemiology, looked at the breast cancer risks for women based on how similarly their diets fell in line with the Dietary Approaches to Stop Hypertension (DASH) diet, which includes lots of vegetables and fruit, beans and nuts, low-fat dairy and grains with fiber.

The researchers found that women with the highest DASH scores had a 20 percent decreased risk of developing estrogen receptor negative breast cancer, which accounts for about a quarter of all breast cancers, Reuters reported.

However, it's important to note that this is simply an association between a plant-heavy diet and a decreased risk of the breast cancer, not proof that the diet can actually prevent cancer, Reuters reported.

The study included 86,000 women, followed for 26 years, of whom less than 1 percent developed estrogen receptor-negative breast cancer. Researchers said they weren't positive why this particular kind of diet seemed linked with the incidence of the breast cancer. However, they told Reuters that it could be because other kinds of cancers have other factors that outweigh the beneficial effects from diet.

"When I found out, I was desperate because I thought I was going to die," said Flor, 46, an undocumented women who asked that her name not to be revealed. "I didn't want to look for help because of my immigration status."

Instead she did what neighbors told her to do for breast cancer: drink tea from a yerberia–an alternative medicine store–and use homemade ointments to reduce the swelling.

When she arrived at the clinic two years ago, she was diagnosed with stage IV breast cancer, a form of advanced cancer that begins in the breast and spreads to other organs. This type of cancer cannot be cured, but it can be treated. For now Flor's condition is stable, but she will never be in remission, where her symptoms disappear.